ERAS - Erasca Quarterly EPS earnings growth

Brandmark of Erasca Corp (ERAS)

Erasca, Inc. (ERAS) focuses on attracting top scientists to develop targeted therapies. This innovative therapy blocks all survival pathways of mutated cells, while costs are minimized through asset virtualization and the outsourcing of tests. The quarterly EPS growth rate on the GURU.Markets chart demonstrates profit dynamics, where the -18.20 level captures the latest values.

Erasca (ERAS) - Earnings per share growth in annualized terms for the last twelve months from 07/04/2022 to 11/11/2026

ERAS (Erasca Oncology): analytical breakdowns and indicator data

- market value and analyst target forecast:
Price Chart Erasca|ERAS - Fair Value Consensus
- market capitalization statistics:
Market Capitalization Erasca Corp|ERAS - Total Enterprise Value
- balance sheet net asset value indicators:
Book Value per Share Erasca|ERAS - Total Stockholders' Equity|Market Value to Book Value Ratio erasca.com|ERAS - Aggregate Asset Value
- company liabilities and liquidity data:
Total Debt to Capital Erasca, Inc.|ERAS - Long-Term Debt to Capital|Short-Term Debt to Equity Erasca, Inc.|ERAS - Company Total Debt Obligations|Debts to Book Capitalization Erasca Corp|ERAS - Company Long-Term Liabilities|Company Short-Term Debts Erasca|Quick Liquidity Indicator erasca.com
- earnings and valuation multiples indicators:
ERAS - Final Profit|Projected Future Earnings Erasca, Inc.|ERAS - Business Payback Period|Future Price to Earnings Erasca Corp|ERAS - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Erasca Corp|ERAS - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Erasca|ERAS - Net earnings per share for the last four quarters|Quarterly EPS earnings growth erasca.com|ERAS - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Erasca, Inc.
Analysis of all company metrics:Erasca - ERAS
Flagship merchandise of Erasca, Inc.

For Erasca, Inc. (ERAS), which develops oncology drugs through external contractors, this indicator reflects the dynamics of net earnings per share. The metric captures rolling quarterly growth, providing real-time signals regarding shifts in the business's operational efficiency. By analyzing the history of quarterly EPS growth, an investor can discern current profitability without waiting for official reports. The lack of manufacturing dependency reduces costs, which directly impacts the volatility of this indicator. A sharp spike in the metric may temporarily mask a subsequent compression of margins.

Main competitors

BeiGene (ONC) - Year-over-year earnings per share growth for the last twelve months|Halozyme Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|RVMD (RevMed) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Ascentage Pharma Corp AAPG|Quarterly EPS earnings growth CGON|URGN - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Bicara Therapeutics BCAX|Year-over-year earnings per one share growth for the last 12 months PSNL|Delcath - Quarterly EPS earnings growth|YMAB - Quarterly EPS earnings growth|Aura Biosciences, Inc. (AURA) - Year-over-year earnings per share growth for the last twelve months|CADL - Year-over-year net earnings per share change for the last twelve months|ARAY (Accuray) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months SELLAS Life Sciences Group Inc. (SLS)|Quarterly EPS earnings growth ACTU|Quarterly EPS earnings growth Citius Oncology Inc (CTOR)|TuHURA Biosciences - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months TARA|Fate Therapeutics - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Aadi Bioscience Inc WHWK|tscan.com (TCRX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months CSBR|XBIT (XBiotech Inc) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months CEL-SCI Corp (CVM)|Year-over-year net earnings per share growth for the last 12 months OSTX (OS Therapies)|Year-over-year net earnings per share change for the last twelve months Radiopharm Theranostics Ltd|Quarterly EPS earnings growth ARTV (Artiva Biotherapeutics)|Adlai Nortye Ltd (ANL) - Earnings per share growth in annualized terms for the last twelve months|VERU - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months TPST (tempesttx.com)|XLO: Quarterly EPS earnings growth|Renovaro (RENB) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Mural Oncology PLC|Kairos Pharma Inc (KAPA) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth OKUR|Year-over-year net earnings per share growth for the last 12 months w2.cytomed.sg GDTC|Quarterly EPS earnings growth CRIS (Curis)|Quarterly EPS earnings growth Apollomics Inc. APLM|THAR - Year-over-year earnings per share growth for the last twelve months|ADVB (Advanced Biomed Inc) - Year-over-year earnings per share growth for the last 12 months|GNPX: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Calidi Biotherapeutics, Inc.|SBFM (Sunshine Biopharma) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Xenetic Bio XBIO|Year-over-year earnings per share growth for the last twelve months Salarius (SLRX)|PPBT (Kitov Pharma) - Year-over-year earnings per one share growth for the last 12 months|American Oncology Network, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months BGNE|Checkpoint Therapeutics, Inc. - Quarterly EPS earnings growth|Elevation Oncology Inc. (ELEV) - Year-over-year net earnings per share growth for the last 12 months|ICAD (icadmed.com) - Year-over-year net earnings per share growth for the last 12 months|Ikena Oncology (IKNA) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Notable Labs, Ltd.|VIRX: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth MOR|NAYA - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth AAPGV (Ascentage Pharma Group Ltd)